| Short Description : | Recombinant-Human IFN-alpha 2-C-His protein was developed in hek293 cells using the region Cys24-Glu188. For use in research applications. |
| Host: | HEK293 cells |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Formulation: | Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Immunoreactivity: | 1.Measured by its binding ability in a functional ELISA.Immobilized Human IFNA2 at 2 Mu g/mL (100 Mu L/well) can bind Human IFNAR2 with a linear range of 0.2-617ng/mL.|2.Recombinant human IFN-Alpha 2 (10 ng/mL) was used to treat HCT116 cells. Western |
| Determination Method: | Please contact us for more information. |
| Gene Symbol: | IFNA2 |
| Gene ID: | 3440 |
| Uniprot ID: | IFNA2_HUMAN |
| Immunogen: | Recombinant Human IFN-alpha 2 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Cys24-Glu188) of human Interferon alpha 2/IFNA2 (Accession #NP_000596.2) fused with a 6×His tag at the C-terminus. |
| Immunogen Region: | Cys24-Glu188 |
| Immunogen Sequence: | CDLPQTHSLGSRRTLMLLAQ MRKISLFSCLKDRHDFGFPQ EEFGNQFQKAETIPVLHEMI QQIFNLFSTKDSSAAWDETL LDKFYTELYQQLNDLEACVI QGVGVTETPLMKEDSILAVR KYFQRITLYLKEKKYSPCAW EVVRAEIMRSFSLSTNLQES LRSKE |
Information sourced from Uniprot.org
